SF5

CAS No. 34634-22-5

SF5( SF-5 | SF 5 | 2,2-Diphenylethylisothiocyanate )

Catalog No. M27794 CAS No. 34634-22-5

SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
25MG 39 In Stock
50MG 56 In Stock
100MG 77 In Stock
200MG Get Quote In Stock
500MG 184 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SF5
  • Note
    Research use only, not for human use.
  • Brief Description
    SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
  • Description
    SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.(In Vitro):SF5 shows strong cell survival effect of kidney epithelial cells (93% at a concentration of 2.5 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SF-5 | SF 5 | 2,2-Diphenylethylisothiocyanate
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    ribonucleotide reductase(RR)|Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    34634-22-5
  • Formula Weight
    239.34
  • Molecular Formula
    C15H13NS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S=C=NCC(c1ccccc1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Larsen IK, et al. Caracemide, a site-specific irreversible inhibitor of protein R1 of Escherichia coli ribonucleotide reductase. J Biol Chem. 1992 Jun 25;267(18):12627-31.
molnova catalog
related products
  • 3-Deoxyaconitine

    3-?Deoxyaconitine is a derivative of Aconitine (A189875), which activates tetrodotoxin-sensitive Na+ channels, inducing presynaptic depolarization.

  • SCFSkp2-IN-2

    SCFSkp2-IN-2, a Skp2 inhibitor, exhibits a dissociation constant (K_D) of 28.77 μM. It demonstrates antitumor activities by inducing apoptosis in non-small cell lung cancer (NSCLC) cells.

  • Trk-IN-9

    Trk-IN-9 (Compound 12) is a potent inhibitor of TRK that inhibits the proliferation of Km-12 cell lines and induces apoptosis in a concentration-dependent manner.